Search clinical trials for: RMZL

Total 8 results

BeiGene

Recruiting

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditions

China, Australia
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy

Sedation

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery

Anesthesia for Elective Surgery Patients

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

Sedation

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers

Anesthesia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Sedation

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers

Healthy

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Sedation

China

3

Subscribe